Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00655993 · ClinicalTrials.gov registry record · Phase 1
Effect of Statin Therapy on C-reactive Protein Levels in Patients With Chronic Obstructive Lung Disease (COPD)
A Phase 1 study of Inflammation and COPD, sponsored by VA Loma Linda Health Care System.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT00655993: Completed Phase 1 study of Inflammation and COPD, sponsored by VA Loma Linda Health Care System.
NCT00655993 is a Phase 1 study of Inflammation and COPD that has completed, run by VA Loma Linda Health Care System. The registered enrollment target is 30 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00655993, a Phase 1 study of Inflammation and COPD, has completed, sponsored by VA Loma Linda Health Care System.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypothesis for this pilot study is that simvastatin will lower the levels of CRP and ET-1 in COPD patients.
Conditions Studied
Interventions
- DRUG simvastatin
Study Locations (1)
California
- VA Loma Linda Health Care System - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-04 |
| Est. Completion | 2014-08 |
| Phase | Phase 1 |
What the finished NCT00655993 record still lists
NCT00655993 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Inflammation appearing as the primary indexed condition, and to 1 intervention - of which simvastatin is the first listed.
NCT00655993 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00655993 about?
NCT00655993 is a clinical study titled "Effect of Statin Therapy on C-reactive Protein Levels in Patients With Chronic Obstructive Lung Disease (COPD)". Hypothesis for this pilot study is that simvastatin will lower the levels of CRP and ET-1 in COPD patients.
What is the current status of trial NCT00655993?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2008-04. Estimated completion is 2014-08.
What conditions does trial NCT00655993 study?
This clinical trial studies the following conditions: Inflammation, COPD.
What interventions are being tested in trial NCT00655993?
The interventions under investigation include: simvastatin (DRUG).
Who is sponsoring clinical trial NCT00655993?
This trial is sponsored by VA Loma Linda Health Care System, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00655993 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00655993's enrollment target sits among peer trials
30 98th of 132 higher than 27 of 132 other Inflammation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Novel Approaches for Improving Vascular Function in Veterans With HFpEF
RECRUITING · Phase 1
-
Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study
RECRUITING · Phase 1
-
Salt-Sensitivity and Immunity Cell Activation
ACTIVE NOT RECRUITING · Phase 1
-
Effects of Etravirine on Endothelial Function in HIV-uninfected Adults: A Pilot Study
COMPLETED · Phase 1
-
Flaxseed Modulates Inflammation and Oxidative Stress in CF
COMPLETED · Phase 1
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia